US equities |
MU $1,064.84 ▼-2.13% NVDA $235.46 ▼-0.85% PLTR $200.40 ▲+3.24% SNDK $1,644.72 ▼-2.82% META $722.64 ▲+0.18% AMD $638.75 ▼-1.10% TSLA $372.81 ▼-1.32% GOOGL $351.62 ▲+0.32%
FinancialContent

Lipocine Inc. - Common Stock (NQ:LPCN)

1.940 -0.260 (-11.82%)
Delayed Quote Updated: 10:06 AM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lipocine Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
On Friday, there are stocks with unusual volume. Let's take a look. ↗
Which stocks have an unusual volume on Friday? 
Via Chartmill
Topics Artificial Intelligence
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
On Monday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
News headline image
LPCN Stock Earnings: Lipocine Beats EPS for Q1 2024 ↗
LPCN stock results show that Lipocine beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
LPCN Stock Earnings: Lipocine Beats EPS for Q4 2023 ↗
LPCN stock results show that Lipocine beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Why Is Lipocine (LPCN) Stock Up 32% Today? ↗
Lipocine (LPCN) stock is rising higher on Thursday after the company released positive results from a Phase 2 clinical trial. 
Via InvestorPlace
Here are the top movers in Thursday's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-04-02: top gainers and losers in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Recap: Lipocine Q1 Earnings ↗
 
Via Benzinga
News headline image
2026 Asset Growth: Why Federal Compliance Is the New Metric
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. 
From Equity Insider
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024 ↗
LPCN stock results show that Lipocine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
7 Penny Biotech Stocks to Triple Your Investment ↗
Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Lipocine Stock Is Moving Higher Today? ↗
Lipocine Inc (NASDAQ: LPCN) shares are trading higher after the company released topline results from a Phase 2 clinical study of LPCN 1148, an oral candidate under development for the  
Via Benzinga
News headline image
Why Is National Vision (EYE) Stock Down 12% Today? ↗
National Vision (EYE) stock is dropping on Thursday as a deal it has with Walmart (WMT) is going to come to an end in 2024. 
Via InvestorPlace
News headline image
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
News headline image
Why Is Yellow (YELL) Stock Down 27% Today? ↗
Yellow (YELL) stock is falling on Thursday as reports claim the transportation company is preparing to file for bankruptcy. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time to start off the day right with an overview of all the biggest pre-market stock movers traders need to know about on Thursday! 
Via InvestorPlace
News headline image
Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales. 
Via Benzinga
< Previous 1 2 3 Next >